Viruses commonly antagonize innate immune pathways that are primarily driven by 19
unbiased RNA-seq based approach to measure gene expression induced by 23 transfected viral genomic RNA (vgRNA) and reovirus infection, we discovered that 24 mammalian reovirus inhibits host cell innate immune signaling. We found that while 25 vgRNA and reovirus infection both induce a similar IRF dependent gene expression 26 program, gene expression driven by the NF-κB family of transcription factors is lower in 27 infected cells. Potent agonists of NF-κB, such as Tumor Necrosis Factor alpha (TNFα) 28 and vgRNA, failed to induce NF-κB dependent gene expression in infected cells. We 29 demonstrate that NF-κB signaling is blocked due to loss of critical members of the 30 Inhibitor of KappaB Kinase (IKK) complex, NF-κB Essential MOdifier (NEMO) and IKKβ. 31 The loss of the IKK complex components prevents nuclear translocation and 32 phosphorylation of NF-κB, thereby preventing gene expression. Our studies 33 demonstrate that reovirus infection selectively blocks NF-κB, likely to counteract its 34 antiviral effects and promote efficient viral replication. 35 36 IMPORTANCE 37
Host cells mount a response to curb virus replication in infected cells and prevent 38 infection of neighboring, as yet uninfected cells. The NF-κB family of proteins is 39 important for the cell to mediate this response. In this study, we show that in cells 40 infected with mammalian reovirus, NF-κB is inactive. Further, we demonstrate that NF-41 κB is rendered inactive because virus infection results in reduced levels of upstream 42 intermediaries (called IKKs) that are needed for NF-κB function. Based on previous 43 evidence that active NF-κB limits reovirus infection, we conclude that inactivating NF-κB 44 is a viral strategy to produce a cellular environment that is favorable for virus replication. 45
INTRODUCTION 46
The mammalian innate immune response is an effective response to viral intrusion. The 47 primary mechanism of innate control of virus infection is the production of antiviral 48 cytokines. Paracrine signaling by these cytokines establishes an antiviral state in 49 neighboring, uninfected cells, making them refractory to virus infection and limiting 50 dissemination of virus in the host (1). Expression of these cytokines is under the control 51 of two major transcription factors, Nuclear Factor-κB (NF-κB) and Interferon Regulatory 52
Factor 3 (IRF3) (2). NF-κB and IRF3 are activated downstream of a signal that is 53 initiated by sensing of pathogen-associated molecules extracellularly, within transit 54 through cellular uptake pathways, or within the cell (2). For RNA viruses, cell surface or 55 endosomal sensing of the genomic material via Toll like Receptors (TLRs), or 56 cytoplasmic sensing via the RIG-I like Receptors (RLRs) are two major mechanisms of 57 pathogen recognition (2). Animal models and cell lines lacking any component of the 58 signaling module -sensor, transcription factors, or cytokines -are typically more 59 susceptible to viral infections than those with an intact immune response (3) (4) (5) (6) . 60
Because these initial stages of the innate immune response are so effective at 61 limiting viral replication, most viruses have evolved one or more mechanisms to limit 62 either the production or activity of these anti-viral cytokines (7, 8) . Frequently, viruses 63 antagonize the immune response by sequestering, degrading, or inactivating one or 64 more cellular components that are required for a cytokine based antiviral response (7, 65 8) . Targeting transcription factor function is a commonly used viral strategy, perhaps 66 because transcription factors serve a critical node that controls the expression of 67 multiple antiviral molecules. Among these, NF-κB can control the function of a wide 68 variety of pro-inflammatory chemokines and cytokines (9). The NF-κB transcription 69 factor family is composed of five different subunits that function as homo or 70 heterodimers. The classical NF-κB complex (henceforth referred to as NF-κB), 71 composed of p65 and p50 subunits, is a critical regulator of antiviral gene expression 72 (9). In an inactive state, it is sequestered in the cytoplasm by the Inhibitor of κB (IκB) 73 inhibitor proteins (9). NF-κB transcriptional activity is regulated by the IκB Kinase (IKK) 74 complex (9). The IKK complex, which is composed of IKKα, IKKβ, and NEMO, 75 phosphorylates IκB, which leads to its ubiquitination and degradation. Freed from its 76 inhibitor, NF-κB is able to translocate to the nucleus, bind to DNA, and initiate gene 77 expression. The transactivation function of NF-κB also requires IKK-mediated 78 phosphorylation of the p65 subunit (10). 79
Mammalian orthoreovirus (reovirus) is a dsRNA virus which replicates in the 80 cytoplasm of the host cell (11). Like most other viruses, reovirus pathogenesis is 81 influenced by NF-κB signaling (12). In a newborn mouse model, NF-κB plays an 82 antiviral role in the heart. In comparison to wildtype mice, NF-κB p50 -/-mice exhibit 83 higher viral titers, tissue damage, and cell death, indicating that NF-κB is antiviral in this 84 context. This outcome, at least in part, is due an inability of p50-/-mice to produce IFNb. 85
Despite the fact that the viral genomic RNA remains within the two concentric protein 86 shells that comprise the reovirus capsid, the current model posits that the innate 87 immune response is initiated when genomic RNA from incoming virions is sensed by 88 the RLRs - 13) . The sensing of the RNA leads to the activation of 89 IRF3 and NF-κB, which lead to the production of IFN and other inflammatory cytokines 90 (14) . Whether reovirus actively limits this antiviral response has not been extensively 91 scrutinized. 92
In this study, we investigated whether reovirus inhibits innate immune signaling 93 following infection. Using RNA-seq, we found that NF-κB activity was inhibited in 94 infected cells following treatment with multiple agonists including viral genomic RNA 95 (vgRNA) and Tumor Necrosis Factor alpha (TNFα). We discovered that this inhibition 96 was due to reduced cellular levels of the IKK components, IKKβ and NEMO. Loss of the 97 IKK complex led to inhibition of NF-κB nuclear translocation and consequent blockade 98 of its transactivation function. Blockade of viral gene expression prevented IKK loss, 99 suggesting that events in viral replication after cell entry are required for IKK loss and 100 NF-κB inhibition. This study highlights a previously unknown mechanism by which 101 reovirus infection blunts the host innate immune response. 102
103

RESULTS
104
NF-κB dependent gene expression is blocked in reovirus-infected cells. The 105
genomic dsRNA within reovirus particles serves as the pathogen associated molecular 106 pattern that activates the innate immune response via . To 107 determine if reovirus infection modifies this response, we compared the host cell 108 response in L929 cells following transfection of vgRNA with the response following 109 infection with reovirus strain type 3 Abney (T3A). Using RNA-seq analyses, we found 110 that viral RNA transfection induced the expression of 978 genes ( Fig. 1A, 1B ). For these 111 analyses, we considered only those genes whose expression was increased > 4 fold 112 (log2FC > 2) and were identified with false discovery rate (FDR) of < 0.05 to be 113 significantly different. We used iRegulon, which predicts transcriptional regulators for a 114 similarly expressed gene set by providing a Normalized Enrichment Score (NES) (18). A 115 high NES for a given transcription factor indicates that many of the genes in a set are 116 likely regulated by that transcription factor. We used this program to identify which 117 transcription factors most likely regulate the genes induced following treatment with 118 vgRNA. We found that, of the 978 genes induced by vgRNA, the highest NES scores 119 were assigned to NF-κB and IRF, with scores of 4.0 and 10.0 respectively (Fig. 1C ). 120
Predictably, reovirus infection induced a similar gene expression profile. 65% of the 978 121 genes induced by vgRNA were also induced by reovirus. When we used iRegulon to 122 predict the transcription factors which regulate the genes induced by reovirus infection, 123 we found that, while genes regulated by IRF were enriched in this list (NES of 12.0), 124 genes regulated by NF-κB were not. Surprisingly, the NES for NF-κB fell below the 3.0 125 cutoff indicating that NF-κB target genes were not enriched in the set of genes induced 126 by reovirus infection (Fig. 1C ). Of the 978 genes induced by vgRNA described above, 127 35% of genes (339 of 978) were expressed to a lower extent in reovirus infected cells. 128
Using iRegulon, we predicted that NF-κB target genes were enriched in this set, as the 129 NES for NF-κB increased from 4.0 to 4.9 (Fig. 1C) . These data suggest that NF-κB and 130 IRF transcription factor families are regulated differently in cells transfected with RNA 131 and cells infected with reovirus. Thus, the observed differences in the gene expression 132 profiles of RNA transfected and reovirus infected cells are not related to differences in 133 RNA sensing. Instead, this difference may be because reovirus fails to activate NF-κB 134 signaling pathway or because it has evolved a mechanism to block NF-κB signaling. 135
To distinguish between these possibilities, we determined whether reovirus 136 infection inhibits vgRNA-induced NF-κB activation. Toward this end, we compared if 137 gene expression in uninfected cells transfected with vgRNA differed from infected cells 138 transfected with vgRNA. As described above, vgRNA transfection of uninfected cells 139 induces expression of 978 genes (Fig. 1A) . In infected cells, however, vgRNA failed to 140 induce 13% of these genes (133 of 978) ( Fig. 1D, 1E ). We used iRegulon to predict that 141 the most likely transcriptional regulator of genes whose expression was inhibited by 142 reovirus infection was NF-κB, with an NES of 6.1. These data allow us to conclude that 143 reovirus blocks NF-κB dependent gene expression even in the presence of a potent 144 agonist. 145 vgRNA and reovirus infection activate NF-κB downstream via a common set of 146 sensors that detect RNA (15) (16) (17) 19) . To determine if the inhibitory effect of reovirus on 147 NF-κB dependent gene expression is only restricted to viral RNA-induced gene 148 expression, we used TNFα, a potent stimulator of NF-κB signaling. RNA-seq analyses 149 of uninfected cells treated with TNFα, using the same criteria described above, led to 150 the upregulation of 32 transcripts ( Fig. 2A) . In contrast, TNFα has no significant effect 151 on gene expression in cells infected with T3A ( Fig. 2B, 2C , 2D). These data indicate 152 that infection of cells with T3A results in blockade of NF-κB-dependent transcription. 153 vgRNA and TNFα initiate NF-κB signaling via distinct routes. Therefore, our analyses 154 suggest that reovirus blocks NF-κB signaling at a step that is shared by both signaling 155 pathways. 156
IκB Kinase (IKK) activity is diminished in reovirus-infected cells. To verify 157
our RNA-seq analyses, we measured the capacity of vgRNA and TNFα to induce the 158 expression of an NF-κB target gene in reovirus infected cells using RT-qPCR. For these 159 experiments we monitored the transcript levels of IκBα, an NF-κB target gene. Because 160 the IκBα protein inhibits NF-κB nuclear translocation, its expression serves as a 161 feedback inhibitor of NF-κB activity (20) . Consistent with our RNA-seq data, we found 162 that reovirus inhibits IκBα expression to a significant extent following treatment with 163 either agonist ( Fig. 3A, 3B ). Because the effect of reovirus on both NF-κB agonists was 164 equivalent, we used TNFα for the remainder of our experiments. TNFα treatment of 165 cells should promote nuclear translocation of p65. We measured nuclear p65 levels in 166 mock-infected and reovirus-infected cells treated with TNFα. As expected, TNFα 167 treatment of mock infected cells resulted in an accumulation of p65 in the nucleus within 168 1 h ( Fig. 3C ). Prior infection with T3A prevented TNFα driven accumulation of p65 in the 169 nucleus. These data agree with previous evidence indicating that degradation of the 170 IκBα protein is blocked in reovirus infected cells (21). IκBα degradation is initiated by the 171 phosphorylation of IκBα by the IκB Kinase (IKK) complex, which leads to 172 polyubiquitination and subsequent degradation of IκBα by the proteasome (9). Thus, the 173 reduction in nuclear p65 levels in T3A infected cells treated with TNFα may be due to an 174 absence of sufficient levels of active IKK. In addition to IκBα, the IKK complex also 175 phosphorylates p65 at Ser536 prior to nuclear translocation (10). IKK-mediated p65 176
Ser536 phosphorylation is critical for NF-κB dependent gene expression and is 177 considered to be a marker for IKK activity (10). To determine if IKK activity is 178 compromised in T3A-infected cells, we assessed the capacity of TNFα to promote p65 179 phosphorylation at Ser536. While TNFα potently induced p65 phosphorylation in mock 180 infected cells, both basal and TNFα induced p65 phosphorylation was dramatically 181 reduced in T3A-infected cells ( Fig. 3D ). Thus, in reovirus infected cells, p65 nuclear 182 translocation and phosphorylation, both of which require the IKK complex, are inhibited. 183
These data suggest that reovirus may inhibit NF-κB dependent gene expression due to 184 the inactivity of the IKK complex. 185
Levels of IKKb and NEMO are diminished following reovirus infection.
To 186 determine the basis of IKK inactivity following infection with T3A, we examined the 187 levels of IKKβ and NEMO, key IKK components that are required for NF-κB activation 188 following TNFα treatment. We found that levels of IKKβ and NEMO are dramatically 189 lower at 12 and 24 h following infection with T3A ( Fig. 4A, 4B ). In contrast, levels of an 190 upstream signaling protein, RIP1, was unaffected by T3A infection. Similarly, levels of 191 NF-κB constituents p50 and p65 also remained constant. These data indicate that T3A-192 mediated diminishment in levels of IKKβ and NEMO likely contributes to a reduction in 193 IKK activity and resultant blockade of NF-κB in infected cells. Because IKKβ is the 194 catalytic component of the IKK complex that is required for IκBα and p65 Ser536 195 phosphorylation, we used IKKβ levels as a surrogate to monitor the mechanism by 196 which IKK activity is diminished following infection. 197
Reovirus gene expression is required for the loss of IKKb. To determine the stage 198 of the reovirus replication cycle that is required for the loss of the IKK complex and the 199 inhibition of NF-κB, we treated cells with ribavirin, which diminishes viral gene 200 expression (13, 22) . We found that ribavirin treatment prevented T3A mediated loss of 201 IKKβ (Fig. 5A ). Consistent with this, in cells treated with ribavirin, T3A was no longer 202 able to prevent TNFα-driven nuclear accumulation of p65 ( Fig. 5B ). Further, ribavirin 203 treatment also reduced the capacity of T3A to block NF-κB dependent gene expression 204 ( Fig. 5C ). Together these experiments indicate that one or more viral proteins produced 205 following virus infection or a specific event in viral replication triggers the loss of IKKβ. 206
IKK overexpression restores NF-κB signaling in reovirus infected cells. To define 207
whether blockade of NF-κB by T3A also occurred in other cell lines, we measured the 208 capacity of T3A to influence TNFα induced expression of IκBα in HEK293 cells using 209 RT-qPCR. Analogous to our observation in L929 cells, TNFα failed to induce IκBα gene 210 expression in T3A infected HEK293 cells ( Fig. 6A ). Phosphorylation of p65 at Ser536 211 ( Fig. 6B ) and its nuclear translocation following TNFα treatment were also inhibited ( Fig.  212 6C). Additionally, we noted a decrease in IKKβ levels in comparison to mock infected 213 cells ( Fig. 6B ). To determine if ectopic overexpression of the IKK complex restores NF-214 κB signaling in reovirus infected cells, we transfected cells with constructs expressing 215 tagged forms of IKKβ and NEMO. Overexpression of these constructs was sufficient to 216 induce NF-κB signaling in mock infected cells, as marked by p65 Ser536 217 phosphorylation ( Fig. 6D ). We found that upon infection of cells with T3A, no decrease 218 in IKKβ levels was observed. Correspondingly, IKK overexpression-induced p65 219 phosphorylation remained unaffected by reovirus infection. These data further indicate a 220 link between IKKβ levels and NF-κB activity in reovirus infected cells. Thus, we 221 conclude that diminishment in IKKβ and NEMO levels is a key mechanism of reovirus-222 induced blockade of NF-κB signaling. 223
DISCUSSION 224
In this study, we sought to evaluate if reovirus infection alters the cellular response to 225 pathogen invasion. Using RNA-seq, which allowed us to examine changes in the global 226 transcriptional landscape, we found that target genes of IRF were induced to a similar 227 extent in cells infected with reovirus and cells transfected with vgRNA. NF-κB target 228 genes, however, were expressed to a much lower extent in infected cells in comparison 229 to cells transfected with vgRNA. Moreover, exogenous NF-κB agonists failed to induce 230 a NF-κB dependent gene expression program in infected cells. These data indicate that 231 NF-κB activity is blocked in infected cells. We found that this blockade of NF-κB 232 dependent gene expression is caused by a loss of IKKβ and NEMO, two critical 233 components of the IKK complex. We propose that reovirus inhibits NF-κB to counter its 234 antiviral effects and produce a cellular environment that is conducive for replication. 235
We show here that reovirus infection inhibits NF-κB signaling (Fig. 1, 2 (17). While other work 242 suggests roles for reovirus μ1 and μ2 proteins in activating NF-κB, it is unclear if this 243 effect is through controlling the exposure of vgRNA or via another mechanism (25-27). 244
Regardless, NF-κB activation early in infection does not require viral gene expression. 245
In contrast, our studies presented here indicate that viral gene expression is required for 246 blockade of NF-κB ( Fig. 5 ). Thus, detection of viral RNA activates NF-κB early in 247 infection and expression of one or more viral gene products following establishment of 248 infection results in blockade NF-κB, limiting further signaling through this pathway. 249
Biphasic regulation of NF-κB was also previously suggested (21, 28) . Our work 250
presented here provides an explanation for this phenomenon. Serotype-specific 251 capacity of reovirus to inhibit NF-κB is genetically linked to the genome segment 252 encoding the reovirus attachment protein σ1 (28). Because σ1 properties impact the 253 efficiency of infection and the level of viral gene expression (29), we think that the 254 genetic link between σ1 and NF-κB is indirect and the viral factor responsible for 255 diminishment of IKK levels and blockade of NF-κB signaling remains unknown. 256 NF-κB is an effective pro-inflammatory signaling pathway that curbs infection. 257
Pathogens therefore have evolved mechanisms to limit its activity. Infection with human 258 coronavirus causes a loss of both IKKβ and NEMO through an unknown mechanism 259 (30). The MCMV protein M45 targets NEMO for autophagolysosomal degradation (31). 260
Shigella, an intracellular pathogenic bacteria secretes an effector with E3 ligase activity 261 which targets NEMO for proteasomal degradation (32). In addition to degradation, 262 pathogens also sequester the IKK complex (IAV NS1 protein) or prevent its activation 263 (HCMV, enterovirus)(33-35). Here we show that reovirus infection leads to the loss of 264 both IKKβ and NEMO (Fig. 4) . This loss was not due to differences in the steady state 265 levels of IKKβ mRNA in reovirus infected cells (not shown). It was also independent of 266 the effect of reovirus infection on host translation suggesting that IKKβ levels were 267 controlled post translationally (not shown). Reovirus does not encode a protease, ruling 268 out a direct effect of a viral protease on IKKβ. Preventing acid-dependent protease 269 activity also did not restore IKKβ levels, indicating that lysosomal or autophagic 270 degradation does not contribute to IKK loss (not shown). Thus, our work is in contrast to 271 a previous study which suggested that TRIM29 in alveolar macrophages turns over 272 NEMO via lysosomal degradation (36). Blockade of proteasome activity diminished 273 reovirus infection, precluding us from evaluating the role of the proteasome in IKKβ loss 274 following infection (not shown). Thus reovirus infection leads to IKK loss through a post-275 translational mechanism, likely degradation via a non-lysosomal pathway. 276
What is the physiologic relevance of blockade of the NF-κB signaling pathway by 277 reovirus? A likely reason is because NF-κB can limit virus replication. Which NF-κB 278 target(s) control virus infection has not been identified. An obvious NF-κB target that 279 could inhibit reovirus infection is IFN. However, consistent with previous work 280 suggesting that certain mouse cell types do not require NF-κB for IFN production (37, 281 38), we found in our RNA-seq analyses that inhibition of NF-κB did not affect IFN 282 production ( Fig. 1) . Thus the antiviral effect of NF-κB is independent from IFN. In 283 contrast with IFN, we found that the expression of several other chemokines and 284 cytokines was inhibited in reovirus infected cells. We hypothesize that one or more of 285 these factors negatively regulates reovirus replication. 286
Two previous studies have suggested that reovirus limits the innate immune 287 response. Reovirus can inhibit IFN production by sequestering IRF3 into viral factories 288 (39). Additionally, reovirus can inhibit IFN signaling by nuclear sequestration of IRF9, 289 which functions with STAT1 and 2 to promote expression of IFN stimulated genes (40). 290
While our work did not directly test these ideas, our gene expression analyses indicate 291 that reovirus does not inhibit the function of IRF3 (Fig. 1) . We also do not observe 292 inhibition of the transcriptional complex that contains IRF9 (not shown). Because these 293 previous studies were performed in different cell types and used different reovirus 294 strains, we propose that reovirus has evolved multiple mechanisms to dampen the 295 innate immune response. Our study presented here unveils one such mechanism. 296 Antibodies and reagents. Polyclonal antisera raised against T3D, T1L that have been 313 described (42) were used to detect viral proteins in T3A infected cells. Rabbit antisera 314 specific for IKKβ and p65 Ser536 phosphorylation specific antibody were purchased 315 from Cell Signaling (catalog # 8943, 3033), rabbit antisera specific for p65 and NEMO 316 were purchased from Santa Cruz Biotechnology (catalog # sc-372, sc-8330). Mouse 317 antisera specific for PSTAIR and FLAG was purchased from Sigma-Aldrich (catalog# 318 P7962, F-3165), mouse antisera specific for RIP1 was purchased from BD Biosciences 319 (catalog# 610458) Alexa Fluor-conjugated anti-mouse IgG and anti-rabbit IgG 320 secondary antibodies were purchased from LI-COR. TNFα was purchased from Sigma 321 and used at a concentration of 10 ng/ml. PSI proteasome inhibitor was purchased from 322
MATERIALS AND METHODS 297
Cells and viruses. Murine L929 cells (ATCC
Millipore and used at a concentration of 20 μM (catalog# 53-916). Ribavirin was 323 purchased from Sigma-Aldrich and used at a concentration of 200 μM (catalog# R9644) 324
Infections. Confluent monolayers of ATCC L929 or HEK293 cells were adsorbed with 325 either PBS or reovirus at the indicated MOI at room temperature for 1 h, followed by 326 incubation with medium at 37°C for the indicated time interval. All inhibitors were added 327 to cells in medium after the 1 h adsorption period. 328 gene from gencode vM17 annotation were counted with strand specificity using 341 featureCounts tool from subread package (45). The differential expression analysis was 342 performed using DESeq2 version 1. 12.3 (46) . 343 iRegulon, a plugin to cytoscape version 3.7.1 was used to predict transcription 344 factor activity based on a differentially expressed gene set (18). A maximum FDR value 345 of motif similarity was set to 0.001. We used a NES value of 3.0 as the minimum cutoff 346 for transcription factor enrichment. D NES was calculated as follows: (NES for 347 vgRNA>Mock) -(NES for experimental condition). 348
Analysis of host gene expression by
RT-qPCR. RNA was extracted from infected cells, at various times after infection, using 349
Aurum Total RNA Mini Kit (Bio-Rad). For RT-qPCR, 0.5 to 2 μg of RNA was reverse 350 transcribed with the high-capacity cDNA RT kit (Applied Biosystems), using random 351 hexamers. cDNA was subjected to PCR using SYBR Select Master Mix using gene 352 Immunoblot Assay. Protein concentrations were estimated using a DC Protein Assay 377 from Bio-Rad. Equal protein was loaded, and the cell lysates or extracts were resolved 378 by electrophoresis in 10% polyacrylamide gels and transferred to nitrocellulose 379 membranes. Membranes were blocked for at least 1 h in blocking buffer (StartingBlock 380 T20 TBS Blocking Buffer) and incubated with antisera against p65 (1:1,000), p65 p-381 Ser536 (1:1,000), p50 (1:500), NEMO (1:500), IKKβ (1:1,000), RIP1 (1:1,000), reovirus 382
(1:5,000), FLAG (1:1,000), and PSTAIR (1:5,000) at 4°C overnight. Membranes were 383 washed three times for 5 min each with washing buffer (Tris-buffered saline [TBS] 384 containing 0.1% Tween-20) and incubated with a 1:20,000 dilution of Alexa Fluor-385 conjugated goat anti-rabbit Ig (for p65, p50, IKKβ, NEMO and reovirus) or goat anti-386 mouse Ig (for PSTAIR, RIP1, and FLAG) in blocking buffer. Following three washes, 387 membranes were scanned and quantified using an Odyssey infrared Imager (LI-COR). 388 37°C for 20 h, cells were transfected with vgRNA and incubated for 7 h. RNA was 431 extracted from cells and levels of IκBα mRNA relative to GAPDH control was measured 432 using RT-qPCR. IκBα expression in mock infected cells treated with agonist vgRNA was 433 set to 100%. Gene expression of each replicate, the mean value, and SD are shown ***, 434 P < 0.001 by Student's t test in comparison to mock infected cells transfected with 435 vgRNA. (B) ATCC L929 cells were adsorbed with PBS (mock) or 10 PFU/cell of T3A. 436
FIGURE LEGENDS 389
Following incubation at 37°C for 20 h, cells were treated with 10 ng/ml TNFα and 437 incubated for 1 h. RNA was extracted from cells and levels of IκBα mRNA relative to 438 GAPDH control was measured using RT-qPCR. IκBα expression in mock infected cells 439 treated with agonist TNFα was set to 100%. Gene expression of each replicate, the 440 mean value and SD are shown **, P < 0.01 by Student's t test in comparison to mock 441 infected cells transfected with vgRNA. (C) ATCC L929 cells were adsorbed with PBS 442 (mock) or 10 PFU/cell of T3A. Following incubation at 37°C for 24 h, cells were treated 443 with 10 ng/ml TNFα and incubated for 1 h. Nuclear extracts were immunoblotted using 444 antiserum specific for p65 or PSTAIR. (D) ATCC L929 cells were adsorbed with PBS 445 (mock) or 10 PFU/cell of T3A. Following incubation at 37°C for 24 h, cells were treated 446 with 20 μM proteasome inhibitor PSI for 1 h, then 10 ng/ml TNFα for 30 min. Whole cell 447 extracts were immunoblotted with antisera specific for p65, p65 Ser536 448 phosphorylation, and PSTAIR. 449 Fig. 1A following vgRNA transfection and T3A infection is shown. Black dots denote genes that are not expressed significantly differently in the two treatments. Red dots represent genes that are expressed to a significantly lower extent in T3A infected cells. iRegulon analyses of both sets of genes is also shown. (D, E) ATCC L929 cells were adsorbed with PBS (mock) or 10 PFU/cell of T3A. Following incubation at 37°C for 20 h, cells were transfected with 0.5 µg viral RNA for 7 h. Total RNA was extracted and subjected to RNA-seq analyses. (D) A heat map comparing expression of genes shown in boxed region of Fig. 1A following vgRNA transfection of mock infected and T3A infected cells is shown. (E) A scatterplot comparing expression of genes shown in boxed region of Fig. 1A following vgRNA transfection of mock infected and T3A infected cells is shown. Black dots denote genes that are not expressed significantly differently in the two treatments. Red dots represent genes that are expressed to a significantly lower extent in T3A infected cells transfected with vgRNA. iRegulon analyses of both sets of genes is also shown. Following incubation at 37°C for 20 h, cells were transfected with vgRNA and incubated for 7 h. RNA was extracted from cells and levels of IκBα mRNA relative to GAPDH control was measured using RT-qPCR. IκBα expression in mock infected cells treated with agonist vgRNA was set to 100%. Gene expression of each replicate, the mean value, and SD are shown ***, P < 0.001 by Student's t test in comparison to mock infected cells transfected with vgRNA. (B) ATCC L929 cells were adsorbed with PBS (mock) or 10 PFU/cell of T3A. Following incubation at 37°C for 20 h, cells were treated with 10 ng/ml TNFα and incubated for 1 h. RNA was extracted from cells and levels of IκBα mRNA relative to GAPDH control was measured using RT-qPCR. IκBα expression in mock infected cells treated with agonist TNFα was set to 100%. Gene expression of each replicate, the mean value and SD are shown **, P < 0.01 by Student's t test in comparison to mock infected cells treated with vgRNA. (C) ATCC L929 cells were adsorbed with PBS (mock) or 10 PFU/cell of T3A. Following incubation at 37°C for 24 h, cells were treated with 10 ng/ml TNFα and incubated for 1 h. Nuclear extracts were immunoblotted using antiserum specific for p65 or PSTAIR. (D) ATCC L929 cells were adsorbed with PBS (mock) or 10 PFU/cell of T3A. Following incubation at 37°C for 24 h, cells were treated with 20 μM proteasome inhibitor PSI for 1 h, then 10 ng/ml TNFα for 30 min. Whole cell extracts were immunoblotted with antisera specific for p65, p65 Ser536 phosphorylation, and PSTAIR. Following incubation at 37°C for 24 h, cells were treated with 10 ng/ml TNFα and incubated for 1 h. Nuclear extracts were immunoblotted using antiserum specific for p65 or PSTAIR. (C) ATCC L929 cells were adsorbed with PBS (mock) or 10 PFU/cell of T3A in the presence of 0 or 200 µM ribavirin. Following incubation at 37°C for 24 h, cells were treated with 10 ng/ml TNFα and incubated for 1 h. RNA was extracted from cells and IκBα gene expression was measured using RT-qPCR. Gene expression in mock infected cells treated with TNFα was set to 100%. Gene expression of each replicate, the mean value and SD are shown. *, P < 0.05 by Student's t test in comparison to mock infected cells treated with TNFα. NS, not significant in comparison to mock infected cells treated with TNFα. HEK293 cells were adsorbed with PBS (mock) or 10 PFU/cell of T3A. Following incubation at 37°C for 24 h, cells were treated with 10 ng/ml TNFα and incubated for 1 h. RNA was extracted from cells and IκBα gene expression was measured using RT-qPCR. Gene expression in mock infected cells treated with TNFα was set to 100%. Gene expression of each replicate, the mean value and SD are shown. *, P < 0.05 by Student's t test in comparison to mock infected cells treated with TNFα. (B) HEK293 cells were adsorbed with PBS (mock) or 10 PFU/cell of T3A. Following incubation at 37°C for 24 h, cells were treated with proteasome inhibitor PSI for 1 h, then 10 ng/ml TNFα for 30 min. Whole cell extracts were immunoblotted using antiserum specific for IKKβ, p65 Ser536 phosphorylation, p65, and PSTAIR. (C) HEK293 cells were adsorbed with PBS (mock) or 10 PFU/cell of T3A. Following incubation at 37°C for 24 h, cells were treated with 10 ng/ml TNFα and incubated for 1 h. Nuclear extracts were immunoblotted using antiserum specific for p65 or PSTAIR. (D) HEK293 cells were transfected with vectors expressing Flag-tagged IKKβ and NEMO. Following incubation at 37°C for 24 h, HEK293 cells were adsorbed with PBS (mock) or 10 PFU/cell of T3A. Following an additional incubation at 37°C for 24 h, whole cell extracts were immunoblotted using antiserum specific for FLAG, p65, p65 Ser536 phosphorylation, reovirus and PSTAIR.
